skip to primary navigationskip to content

19.07.17 Huch lab wins project grant to develop patient-specific 'liver cancer organoids'

last modified Jul 19, 2017 03:04 PM
The NC3Rs has awarded a project grant to Meri Huch to explore how to grow liver cancer organoids from tumour biopsies, replacing the use of animals for such research
19.07.17 Huch lab wins project grant to develop patient-specific 'liver cancer organoids'

Liver organoids from mice, such as this, could be replaced by those grown from human tissue biopsies

Replacing liver cancer models by modelling human liver cancer in vitro


This is the title of Meri Huch's latest research project, one of nine new project awards by the National Centre for the Replacement Refinement & Reduction of Animals in Research (NC3Rs). 

We currently lack good liver cancer models that faithfully represent the genetic variability of human liver cancer, and indeed the majority of existing animal models (from mice to dog) do not replicate the human disease. This poses a problem for researchers wishing to design therapeutic strategies and test potential drug compounds. What we need is a system of liver cancer cultures that can be obtained in a timely manner from the patient, expanded and maintained long term, and that are easy to manipulate.

The Huch lab have pioneered the liver organoid culture system whereby human cells in vitro can grow into three-dimensional structures mimicking the liver. These organoids have already been shown to model two different liver genetic diseases.  The new funding from the NC3Rs now allows the group to explore how organoids could be grown from patients' tunour biopsies using the same system, to provide a patient-specific model of liver cancer in the culture dish. 

This will allow for personalised anti-cancer therapeutic strategies to be tested, and for the study of human liver cancer biology in general, replacing the use of animals in liver cancer research and drug testing.


See the full news item on the NC3Rs website.

Read more about research in the Huch lab.

Watch Meri describe her work on organoids on our YouTube channel.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018


Share this

Immune Cell Dynamics Unfolded by Single-Cell Technologies

Chromatin Accessibility Impacts Transcriptional Reprogramming in Oocytes

Integrin α2 marks a niche of trophoblast progenitor cells in first trimester human placenta

Inhibition of the acetyltransferase NAT10 normalizes progeric and aging cells by rebalancing the Transportin-1 nuclear import pathway

SLAM-ITseq: Sequencing cell type-specific transcriptomes without cell sorting

SRSF3 maintains transcriptome integrity in oocytes by regulation of alternative splicing and transposable elements

scmap: projection of single-cell RNA-seq data across data sets

Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis

Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48

The developmental origin of brain tumours: a cellular and molecular framework

Bioinformatics challenges and perspectives when studying the effect of epigenetic modifications on alternative splicing

ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks

Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity

Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer

Predominant Asymmetrical Stem Cell Fate Outcome Limits the Rate of Niche Succession in Human Colonic Crypts

G9a regulates temporal preimplantation developmental program and lineage segregation in blastocyst

Link to full list on PubMed